Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diabetes and Ramadan: Practical guidelines 2021.
Hassanein M, Afandi B, Yakoob Ahmedani M, Mohammad Alamoudi R, Alawadi F, Bajaj HS, Basit A, Bennakhi A, El Sayed AA, Hamdy O, Hanif W, Jabbar A, Kleinebreil L, Lessan N, Shaltout I, Mohamad Wan Bebakar W, Abdelgadir E, Abdo S, Al Ozairi E, Al Saleh Y, Alarouj M, Ali T, Ali Almadani A, Helmy Assaad-Khalil S, Bashier AMK, Arifi Beshyah S, Buyukbese MA, Ahmad Chowdhury T, Norou Diop S, Samir Elbarbary N, Elhadd TA, Eliana F, Ezzat Faris M, Hafidh K, Hussein Z, Iraqi H, Kaplan W, Khan TS, Khunti K, Maher S, Malek R, Malik RA, Mohamed M, Sayed Kamel Mohamed M, Ahmed Mohamed N, Pathan S, Rashid F, Sahay RK, Taha Salih B, Sandid MA, Shaikh S, Slim I, Tayeb K, Mohd Yusof BN, Binte Zainudin S. Hassanein M, et al. Among authors: hanif w. Diabetes Res Clin Pract. 2022 Mar;185:109185. doi: 10.1016/j.diabres.2021.109185. Epub 2022 Jan 8. Diabetes Res Clin Pract. 2022. PMID: 35016991 Review.
Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits.
Thong KY, Ryder RE, Cull ML, Walton C; ABCD Nationwide Exenatide and Liraglutide Audit Contributors. Thong KY, et al. Diabet Med. 2012 May;29(5):690-2. doi: 10.1111/j.1464-5491.2011.03475.x. Diabet Med. 2012. PMID: 21988449 No abstract available.
Review of diabetes management and guidelines during Ramadan.
Karamat MA, Syed A, Hanif W. Karamat MA, et al. Among authors: hanif w. J R Soc Med. 2010 Apr;103(4):139-47. doi: 10.1258/jrsm.2010.090254. J R Soc Med. 2010. PMID: 20382905 Free PMC article. Review. No abstract available.
Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study.
Hassanein M, Hanif W, Malik W, Kamal A, Geransar P, Lister N, Andrews C, Barnett A. Hassanein M, et al. Among authors: hanif w. Curr Med Res Opin. 2011 Jul;27(7):1367-74. doi: 10.1185/03007995.2011.579951. Epub 2011 May 16. Curr Med Res Opin. 2011. PMID: 21568833
A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial.
Brady EM, Davies MJ, Gray LJ, Saeed MA, Smith D, Hanif W, Khunti K. Brady EM, et al. Among authors: hanif w. Diabetes Obes Metab. 2014 Jun;16(6):527-36. doi: 10.1111/dom.12249. Epub 2014 Jan 26. Diabetes Obes Metab. 2014. PMID: 24373063 Clinical Trial.
Guidelines for managing diabetes in Ramadan.
Ali S, Davies MJ, Brady EM, Gray LJ, Khunti K, Beshyah SA, Hanif W. Ali S, et al. Among authors: hanif w. Diabet Med. 2016 Oct;33(10):1315-29. doi: 10.1111/dme.13080. Epub 2016 Feb 25. Diabet Med. 2016. PMID: 26802436 Review.
115 results